Error loading player: No playable sources found

89866

CASSS Welcome & CGTP 2024 Introduction

Date
June 11, 2024
This product is not available for individual purchase, but it is available as part of the following products:


Related Products

Thumbnail for Plenary Session 8 - Global Regulatory Updates and Panel Discussion & Closing Remarks
Plenary Session 8 - Global Regulatory Updates and Panel Discussion & Closing Remarks
The cell and gene therapy field spans an enormous range of product types and technologies with the potential to provide curative treatments for a wide range of serious diseases…
Thumbnail for Plenary Session 1 - Genetic Modification Technologies for Cell-based Gene Therapies
Plenary Session 1 - Genetic Modification Technologies for Cell-based Gene Therapies
In addition to the now well-known CAR T (chimeric antigen receptor T cells) and HSC (CD34+ hematopoietic stem cells) cell-based gene therapies, there are several other modes of gene modification as well as cell types already approved and on the horizon…
Thumbnail for Plenary Session 6 - Fireside Chat: Evolution of Cell and Gene Therapy
Plenary Session 6 - Fireside Chat: Evolution of Cell and Gene Therapy
Join us for an engaging fireside chat delving into the revolutionary landscape of cell and gene therapy…
Thumbnail for Parallel Session 2 - How to Control Off Target Genotoxicity for Genome and Epigenome Editing Medicines
Parallel Session 2 - How to Control Off Target Genotoxicity for Genome and Epigenome Editing Medicines
Genome editing is a tool that enables a new generation of medicines by directly targeting with high precision the genetic cause of a disease. It also allows for immune evasion and prevents microenvironment responses: concepts vital to more potent, off the shelf, cell, and gene therapies…